Detalles de la búsqueda
1.
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
N Engl J Med
; 388(9): 813-823, 2023 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36856617
2.
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.
Cancer
; 130(10): 1784-1796, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38261444
3.
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 22(2): 117-135, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38503056
4.
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.
Lancet
; 400(10357): 1008-1019, 2022 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36108657
5.
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer.
Oncologist
; 28(8): e625-e632, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37085156
6.
Association between pre-treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitis.
Cancer Immunol Immunother
; 72(6): 1727-1735, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36640189
7.
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy.
Cancer Immunol Immunother
; 72(7): 2005-2013, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36738310
8.
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy.
Cancer Immunol Immunother
; 72(11): 3461-3474, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37528320
9.
Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer.
J Natl Compr Canc Netw
; 21(11): 1164-1171.e5, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37935100
10.
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival.
Cancer Immunol Immunother
; 71(5): 1157-1165, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34618180
11.
Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events.
Cancer Immunol Immunother
; 70(10): 2761-2769, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33625533
12.
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.
J Natl Compr Canc Netw
; 19(4): 364-376, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33845460
13.
Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics.
Histopathology
; 77(2): 240-249, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32298485
14.
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications.
BMC Cancer
; 20(1): 383, 2020 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32375706
15.
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.
Cancer
; 125(1): 18-44, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30281145
16.
Hybrid Capture-Based Genomic Profiling Identifies BRAF V600 and Non-V600 Alterations in Melanoma Samples Negative by Prior Testing.
Oncologist
; 24(5): 657-663, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30683711
17.
Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics.
Graefes Arch Clin Exp Ophthalmol
; 257(8): 1771-1781, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31098752
18.
Correction: Association between pretreatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitis.
Cancer Immunol Immunother
; 72(6): 1737, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36806904
19.
Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
J Surg Res
; 214: 32-37, 2017 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28624057
20.
Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.
J Natl Compr Canc Netw
; 13(1): 9-13; quiz 13, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25583765